Maternal and Infant Syphilis Prevention Act

# Maternal and Infant Syphilis Prevention Act Summary **What the Bill Would Do** The Maternal and Infant Syphilis Prevention Act (HR 3866) is designed to address rising rates of syphilis transmission from pregnant women to their newborns. The bill would establish or strengthen federal programs aimed at screening pregnant women for syphilis, treating infected mothers before birth, and preventing transmission to infants. This represents a public health response to a documented increase in congenital syphilis cases across the United States in recent years. **Who It Affects and Key Provisions** The bill primarily affects pregnant women, newborns, and healthcare providers involved in maternal and prenatal care. While specific provisions aren't detailed in available summaries, such legislation typically includes measures like funding for screening programs, treatment protocols, healthcare provider education, and tracking of cases.

The goal is to prevent serious health complications in newborns, including blindness, deafness, developmental delays, and death. **Current Status** As of now, HR 3866 remains in committee, meaning it has not yet been debated or voted on by the full House of Representatives. The bill was introduced by Rep. Juan Ciscomani (R-AZ) in the 119th Congress.